SLC9A1 and pulmonary hypertension: Under conditions of hypoxia, where p-ezrin, and at later time points, NHE1 protein levels are increased, these interactions appear to facilitate changes in PASMC phenotype that would promote vascular remodeling and the development of pulmonary hypertension.